Pharmacovigilance is the process and science of monitoring the safety of medicines and taking action to reduce risks and increase their benefits. The aim is to prevent harm to patients through the identification, understanding and reduction of adverse effects of drugs.
Pharmacovigilance is an important tool for patient care. Through this the risks identified by the use of a drug in the shortest time possible, so any damage this may cause to avoid or minimize. When handled effectively, the information yielded allow rational and informed use of drugs and have the potential to prevent many side effects.
The European Union has set up its own shape pharmacovigilance of the European Medicines Agency (European Medicine Agency-EMA). The service pharmacovigilance develop and maintain a database of all suspected adverse reactions recorded in the EU. The system called Eudravigilance.
The EMA requires from all pharmaceutical companys to electronically submit all reports they receive. Followed by Regulation EC Regulation No 726/2004 and Directives EU Directive 2001/83 / EC for human use. The spontaneous reporting and disclosure of adverse events to the National Medicines Agency is the Yellow Card. The Yellow Card exists in all European Union countries. The filling is simple and short, and the information contained there are confidential and managed dy the EMEA with great sensitivity.
In Gramm Pharmaceuticals, our vision is to contribute to the European effort for patient access to safe and effective drugs. For this reason we have the appropriate pharmacovigilance system for monitoring the safety and efficacy of our products.
If you wish to report a side effect that you think may related to Gramm Pharmaceuticals product, please contact the pharmacovigilance department of the company by phone.
Phone: 2310 760783 (office hours)
FAX: 2310 760714 (24 hours)
Mob. : 6974 196176 (24 hours)
Alternatively you can fill in the contact form
Important Note: Each time you are prescribed a drug, carefully read the entire leaflet carefully before you start taking this medicine, you have been given. In addition, keep the package leaflet (FOCH). If you have any further questions please consult your doctor or pharmacist. This drug you have in your hands was given to you alone. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
If you notice any side effects, talk to your doctor or pharmacist or his / her nurse. This applies to any possible side effects not mentioned in the package leaflet. You may also report side effects to Gramm Pharmaceuticals or the National Organization for Medicines (Mesogion 284.15562, Cholargos, www.eof.gr). Through the reporting of adverse events you can help to gather more information on the safety of medicine